Koyfin Home > Directory > Health Care > Abeona Therapeutics > Cash from Investing Activities

Abeona Therapeutics Cash from Investing Activities Chart (ABEO)

Abeona Therapeutics annual/quarterly Cash from Investing Activities from 2010 to 2020.
  • Abeona Therapeutics Cash from Investing Activities for the quarter ending June 06, 2020 was $-18m a 205.60% decrease of -37m year over year
  • Abeona Therapeutics Cash from Investing Activities for the last 12 months ending June 06, 2020 was $-76m a 183.17% decrease of -139m year over year
  • Abeona Therapeutics Annual Cash from Investing Activities for 2019 was $60m a 241.87% increase of 145m from 2018
  • Abeona Therapeutics Annual Cash from Investing Activities for 2018 was $-85m a 98.99% decrease of -84m from 2017
  • Abeona Therapeutics Annual Cash from Investing Activities for 2017 was $-1m a 39.65% decrease of 0m from 2016
Other Cash Flow Metrics:
  • Abeona Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $-9m a 41.08% decrease of -4m year over year
  • Abeona Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-5m a 46.02% decrease of -2m year over year
  • Abeona Therapeutics Total Revenue for the quarter ending September 09, 2018 was $2m a 87.42% increase of 1m year over year
View Chart On Koyfin

Quarterly ABEO Cash from Investing Activities Data

06/2020$-18m
03/2020$-76m
12/2019$-1m
09/2019$19m
06/2019$19m
03/2019$23m
12/2018$2m
09/2018$-10m
06/2018$-73m
03/2018$-4m

Annual ABEO Cash from Investing Activities Data

2019$60m
2018$-85m
2017$-1m
2016$-1m
2015$3m
2013$0m
2012$0m
2011$0m
2010$0m